Health Technology · Medical Specialties · NSE: MOLBIO · data 2026-10-09

Molbio Diagnostics Limited

Health check: Strong (8.5/10 on quality, valuation vs sector, growth and momentum).

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹1,438.6

Market cap

₹17,048 cr

P/E

—

P/B

—

ROE

—

ROCE

—

Debt / equity

—

Dividend yield

0.00%

1-year return

78.3%

52-week high

₹1,686.8

52-week low

₹807

Operating margin

—

Growth

Revenue (last 12 months)	—
Net profit (last 12 months)	—
Sales growth, 3 years (yearly)	—
Profit growth, 3 years (yearly)	—

Similar companies

Lenskart Solutions Limited (LENSKART) · Poly Medicure Limited (POLYMED) · Standard Engineering Technology Ltd (SETL) · Virtuoso Optoelectronics Limited (VOEPL) · Q-Line Biotech Limited (QLINE)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open MOLBIO in NSE Scanner →